Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.03 +0.01 (+0.98%)
As of: Oct 22, 2026 · 9:39 AM EDT

Cadrenal Therapeutics (CVKD) Non-Current Debt (2022)

Updated

Analysis

Cadrenal Therapeutics (CVKD) Non-Current Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,160.65 Bn 1,129.23 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 633.19 Bn 551.72 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.90 Bn 475.01 Bn 12.70 Bn 62.48 Bn
4 Merck 377.07 Bn 331.45 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 302.35 Bn 266.34 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 23.68 Bn
7 Amgen 240.68 Bn 196.07 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 193.20 Bn 167.40 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 60.50 Bn
10 Cadrenal Therapeutics 3.00 Mn -9.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 250,000.00
API Access

Cadrenal Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CVKD&period=max&api_key=YOUR_API_KEY